Press Releases and Product Information November 9, 2022
advertisement
- Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
- AI Clinical Decision Support Tool Predicts Risk of Diabetes Complications
- Walgreens Teams Up with Its Health Corners and Clinic Partners to Expand Access to Complimentary Diabetes Services during Diabetes Awareness Month
- Lilly to begin rollout of Tempo® Personalized Diabetes Management Platform
- LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM